MYLAN 351 (Haloperidol 0.5 mg)
Pill with imprint MYLAN 351 is Orange, Round and has been identified as Haloperidol 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc..
Haloperidol is used in the treatment of dementia; icu agitation; borderline personality disorder; psychosis; nausea/vomiting (and more), and belongs to the drug class miscellaneous antipsychotic agents. Risk cannot be ruled out during pregnancy. Haloperidol 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 351
Haloperidol
- Imprint:
- MYLAN 351
- Strength:
- 0.5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0733 | UDL Laboratories Inc. |
| 68071-0494 | Nucare Pharmaceuticals Inc. (repackager) |
More about haloperidol
- Haloperidol Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 73 Reviews – Add your own review/rating
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Haloperidol
- Haloperidol injection
- Haloperidol Decanoate Injection
- Haloperidol Oral Solution
- Haloperidol Tablets
- ... +2 more
Other brands: Haldol, Haldol Decanoate
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
